Skip to content

Prevention of the elastic recoil after balloon angioplasty for infrapopliteal zone in patients with chronic limb threateing ischemia

Prevention of the elastic recoil after balloon angioplasty for infrapopliteal zone in patients with chronic limb threateing ischemia - RECOIL ZERO study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000059284
Enrollment
150
Registered
2025-10-03
Start date
2025-05-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic limb threatening ischemia (Below-the-knee)

Interventions

None listed

Sponsors

Tokyo Bay Urayasu Ichikawa Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with symptomatic lower limb occlusive atherosclerosis (Rutherford classification 4-6) for whom below-knee arterial EVT is indicated 2) Patients for whom HP-POBA is determined to be the medically optimal treatment (best practice) for symptomatic atherosclerotic lesions in the below-knee arteries, and for whom HP-POBA is actually planned (Patients may also be enrolled if treatment of other arterial regions is planned concurrently)

Exclusion criteria

Exclusion criteria: 1) Patients for whom limb salvage is unlikely (e.g., due to infection complications) 2) Lesions involving aneurysms in the target vessel

Design outcomes

Primary

MeasureTime frame
The presence or absence of elastic recoil confirmed by angiography 15 minutes later

Secondary

MeasureTime frame
Incidence of procedural complications

Countries

Japan

Contacts

Public Contacttoru matsumura

Clinicalcore Non

matsumura@clinicalcore.jp03-6667-0250

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026